About Riboxx
Riboxx is a Healthcare company based in Radebeul (Germany) founded in 2009. Provider of siRNA reagents, miRNA mimics, and immunomodulators for research application. Riboxx has raised $1.18 million across 3 funding rounds from investors including BMBF and TGFS. The company has 4 employees. Riboxx offers products and services including iVORi siRNA, CONmiR miRNA mimics, RIBOXXOL, and RIGOXXON. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics. Its legal entity is RiboxX GmbH.
Company details
Riboxx was founded in 2009 in Radebeul, Germany, as a provider of siRNA reagents, miRNA mimics, and immunomodulators within the biotechnology sector. Operations are divided into two lines: Riboxx Life Sciences, focused on RNA reagents for life sciences research, and Riboxx Pharma, dedicated to the development and industrial manufacturing of immunomodulators for therapeutic vaccines against cancer and prophylactic vaccines against infections.
- Headquarters Radebeul, Germany
- Employees 4
- SectorsHealthcare
- Email••••••••
- Website riboxx.com
- Social LinkedIn X Facebook
- Legal Name Riboxx Gmbh
- Total Equity Funding$1.18M (USD)
in 3 rounds
- Latest Funding Round$1.18M (USD), Seed
Jan 2015
- InvestorsBMBF
& 1 more
- Employee Count4
Products & Services of Riboxx
Riboxx offers a comprehensive portfolio of products and services, including iVORi siRNA, CONmiR miRNA mimics, RIBOXXOL, and RIGOXXON.
siRNA for in vivo gene silencing in research applications.
Mimics for microRNA functions in biological studies.
Ligands for activating immune responses in experiments.
Ligands for RNA-induced immune activation purposes.
Funding Insights of Riboxx
Riboxx has successfully raised a total of $1.18M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $1.18 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.18M
- Total Rounds 3
- Last Round Seed — $1.18M
- First Round $4.67M
(Jun 2010)
- Investors Count 2
All 3 funding rounds of Riboxx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Riboxx
Riboxx has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include BMBF and TGFS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and support are provided to technology startups in Saxony. | 2008 | tgfs.de | Leipzig, Germany | |
Education and research policies are overseen by the ministry. | 1955 | bmbf.de | Berlin, Germany |
Investor details for Riboxx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Riboxx
3 dated milestones of Riboxx across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Riboxx is founded.
- Funding First funding round of $4.7M.
- Funding Latest funding round, Seed, of $1.2M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Riboxx
Riboxx was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Riboxx is headquartered in Radebeul, Germany. It is registered at Radebeul, Saxony, Germany.
Riboxx is a funded company, having raised a total of $1.18M across 3 funding rounds to date.
Riboxx has 4 employees.
Riboxx was founded in 2009 in Radebeul, Germany, as a provider of siRNA reagents, miRNA mimics, and immunomodulators within the biotechnology sector. Operations are divided into two lines: Riboxx Life Sciences, focused on RNA reagents for life sciences research, and Riboxx Pharma, dedicated to the development and industrial manufacturing of immunomodulators for therapeutic vaccines against cancer and prophylactic vaccines against infections.
Riboxx offers iVORi siRNA, CONmiR miRNA mimics, RIBOXXOL, and RIGOXXON.
Riboxx operates through Riboxx Gmbh.